Tech Company Financing Transactions
Sonablate Funding Round
On 8/6/2026, Sonablate secured $200 million in funding from Eleven Ventures.
Transaction Overview
Company Name
Announced On
8/6/2026
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10130 Perimeter Pkwy 410
Charlotte, NC 28216
USA
Charlotte, NC 28216
USA
Phone
Website
Email Address
Overview
Together, we strive to push focal therapy forward and make a positive impact on patient lives. Sonablate Corp. is a team of diverse individuals from various backgrounds and areas of expertise, all working towards a common goal - providing the best possible care for our patients. We have employees who have worked with our technology since its inception as well as fresh talent who bring expertise from a range of industries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Yang
Chief Financial Officer
Brian Murrell
Chief Information Officer
Brad Farmer
Chief Scientific Officer
Narendra Sanghvi
Chief Technical Officer
Ralf Seip
Vice President
Valerie Ervin
VP - Bus. Development
Yuki Ji
VP - Operations
David Quigley
VP - Regulatory Affairs
Savannah Scarborough
VP - Regulatory Affairs
Louis Ta
VP - Sales
Barton Shannon
Browse more venture capital transactions:
Prev: 8/6/2026: Plantible Foods venture capital transaction
Next: 8/6/2026: Factbird venture capital transaction
Share this article
About Database of VC Transactions
We record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs